rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael D. Kishbauch

Director

Company insider

Files Form 4 as: Director, Astria Therapeutics; CEO and President, Achillion Pharmaceuticals; Director, Progenics Pharmaceuticals; Director, Tetralogic Pharmaceuticals; Director, Ariad Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
97
Buys
0
Sells
9
Bought
$0
Sold
$11.7M
Companies
5
Companies where not an officer
4
First trade
17 Jan 2006
Last trade
23 Jan 2026
Last filed
23 Jan 2026

Companies traded

Where they are an officer
Achillion PharmaceuticalsDirector, Officer · last 28 Jan 20200 buys · 9 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Astria TherapeuticsDirector · Biotechnology · last 23 Jan 20260 buys · 0 sells
Progenics PharmaceuticalsDirector · last 11 Jul 20190 buys · 0 sells
Tetralogic PharmaceuticalsDirector · last 28 Jan 20150 buys · 0 sells
Ariad PharmaceuticalsDirector · last 18 Jan 20080 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—16,666filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—8,333filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—14,100filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivativeSEC FORM 4 Code D—16,666filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivativeSEC FORM 4 Code D—8,333filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivativeSEC FORM 4 Code D—14,100filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivativeSEC FORM 4 Code D—14,100filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivativeSEC FORM 4 Code D—26,550filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—14,100filing
23 Jan 2026filed 23 Jan 2026Astria Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—26,550filing
11 Jun 2025filed 12 Jun 2025Astria Therapeuticsoption or derivativeSEC FORM 4 Code A—26,550 at $0.00filing
5 Jun 2024filed 6 Jun 2024Astria Therapeuticsoption or derivativeSEC FORM 4 Code A—14,100 at $0.00filing
2 Jun 2023filed 6 Jun 2023Astria Therapeuticsoption or derivativeSEC FORM 4 Code A—14,100 at $0.00filing
9 Jun 2022filed 21 Jun 2022Astria Therapeuticsoption or derivativeSEC FORM 4 Code A—8,333 at $0.00filing
9 Jun 2022filed 9 Jun 2022Astria Therapeuticsoption or derivativeSEC FORM 4 Code A—8,333 at $0.00filing
2 Jun 2021filed 2 Jun 2021Catabasis Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—100,000 at $0.00filing
11 Jun 2020filed 12 Jun 2020Catabasis Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—7,500 at $0.00filing
28 Jan 2020filed 29 Jan 2020Achillion Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—30,000filing
28 Jan 2020filed 29 Jan 2020Achillion Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—30,000filing
28 Jan 2020filed 29 Jan 2020Achillion Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—25,000filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed9

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.